Thomas Levato is a partner in Goodwin’s Technology Companies & Life Sciences Group and a member of its Capital Markets Practice. He has extensive experience representing investment banks, issuers and investors in capital markets transactions, including IPOs, follow-on public offerings, rights offerings and private placements of equity, equity-linked and debt securities. His practice covers a variety of industries including life sciences, technology, cleantech, energy, industrials, media and retail/consumer goods.

Mr. Levato is a market leader in alternative financing transactions, including Confidentially Marketed Public Offerings (CMPOs), Registered Direct Offerings (RDs), Private Investments in Public Equity (PIPEs) and At-the-Market Offerings (ATMs). Goodwin is consistently ranked as one of the most active law firms in the United States advising on these transactions.

Mr. Levato also routinely counsels clients on corporate governance matters, SEC compliance, securities and disclosure issues, and the rules and interpretations of the NYSE and NASDAQ.

Experience

ERFAHRUNG

工作经历

Mr. Levato's experience covers capital markets transactions involving both domestic and foreign private issuers. 

Representative Matters

REFERENZMANDATE

代表事项

Life Sciences
  • J.P. Morgan Securities and Morgan Stanley in a follow-on public offering for NPS Pharmaceuticals, Inc.
  • Citigroup and Jefferies in a follow-on public offering for GTx, Inc.
  • Merrill Lynch and Cowen and Company in the initial public offering for TiGenix
  • Merrill Lynch in follow-on public offerings for MEI Pharma, Inc. and Rockwell Medical, Inc.
  • Deutsche Bank Securities in follow-on public offerings for Chelsea Therapeutics International, Ltd., Dyax Corp. and Inhibitex, Inc.
  • Stifel and Piper Jaffray in the initial public offering for Conatus Pharmaceuticals Inc.
  • Wells Fargo Securities, Stifel and Leerink in follow-on public offerings for Zogenix, Inc.
  • Leerink and Cowen and Company in the initial public offering for Bellerophon Therapeutics, Inc.
  • Leerink and Stifel in follow-on public offerings for OncoGenex Pharmaceuticals, Inc.
  • Stifel and JMP Securities in the initial public offering for Marinus Pharmaceuticals, Inc.
  • Piper Jaffray and Stifel in the initial public offering for Innocoll AG
  • Canaccord Genuity in a bought deal for Novadaq Technologies Inc.
  • Wells Fargo Securities in follow-on public offerings for Immunomedics, Inc.
  • Leerink and Cowen and Company in a follow-on public offering for Trillium Therapeutics Inc.
  • Leerink and Stifel in follow-on public offerings for Tekmira Pharmaceuticals Corporation
  • Jefferies in follow-on public offerings for Delcath Systems, Inc. and Compugen Ltd.
  • Cowen and Company in follow-on public offerings for XOMA Corporation, Oncothyreon Inc., Cytokinetics, Inc. and Dynavax Technologies Corporation
  • Canaccord Genuity in follow-on public offerings for MiMedx Group, Inc., Lipocine Inc. and Venaxis, Inc.
  • Stifel in follow-on public offerings for Keryx Biopharmaceuticals, Inc. and Celator Pharmaceuticals, Inc. and a private placement for Strongbridge Biopharma plc
  • Oppenheimer & Co. in follow-on public offerings for BioTime, Inc., ADMA Biologics, Inc., Cleveland BioLabs, Inc. and Pieris Pharmaceuticals, Inc.
  • Pernix Therapeutics Holdings, Inc. in equity and debt financing transactions
  • Anthera Pharmaceuticals, Inc. in equity financing transactions
  • Medicrea International in a debt financing transaction
  • Ampio Pharmaceuticals Inc. in equity financing transactions
  • Baker Bros. Advisors, a life sciences focused hedge fund, as lead investor in numerous public and private portfolio company investments
Technology
  • Goldman, Sachs & Co., Credit Suisse Securities (USA), J.P. Morgan Securities and Morgan Stanley in the initial public offering for Aeroflex Holding Corp.
  • Canaccord Genuity in a follow-on public offering for Sequans Communications S.A.
  • Stifel in follow-on public offerings for Xcerra Corporation, Procera Networks, Inc., Speed Commerce, Inc., Mindspeed Technologies, Inc. and ePlus, Inc.
  • Oppenheimer & Co. in follow-on public offerings for Energous Corporation and MicroVision, Inc.
  • Needham & Company in follow-on public offerings for Numerex Corp., Ikanos Communications, Inc., TranSwitch Corporation and Overland Storage, Inc.
  • Unwired Planet, Inc. in equity financing transactions
CleanTech
  • Stifel in a follow-on public offering for Active Power, Inc.
  • Cowen and Company and Oppenheimer & Co. in follow-on public offerings for GEVO, Inc.
  • Needham & Company in a follow-on public offering for PMFG, Inc.
  • Plug Power Inc. in equity financing transactions
  • Metabolix, Inc. in equity financing transactions
Energy
  • SunTrust Robinson Humphrey in follow-on public offerings for Ring Energy, Inc. and Earthstone Energy, Inc. and a private placement for Sanchez Production Partners LP
  • BMO Capital Markets in follow-on public offerings for NGAS Resources, Inc. and Warren Resources, Inc.
Other
  • Deutsche Bank Securities and Barclays Capital in follow-on public offerings for Orient-Express Hotels Ltd.
  • Jefferies and Deutsche Bank Securities in follow-on public offerings for Solutia Inc.
  • Canaccord Genuity in a bought deal for DHX Media Ltd.
  • Deutsche Bank Securities in follow-on public offerings for Smith & Wesson Holding Corporation

In The News

MELDUNGEN

在新闻中

Credentials

WERDEGANG

专业资格

Education

J.D., 2000
The George Washington University Law School

(with honors)

B.A., 1995
Bucknell University

Admissions

Bar

New York
New Jersey
Get In Touch
KONTAKT
Get In Touch
联系我们
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Unsere Kunden verlassen sich auf uns für erstklassige Beratungsdienste, beraten über komplexe Transaktionsarbeiten und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Industrie, verwenden wir eine kooperative, interdisziplinäre Ansatz zur Lösung unserer Kunden am schwierigsten Fragen. Um mehr zu erfahren, kontaktieren Sie uns bitte.

客户信赖我们世界一流的咨询服务,希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题,涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息,请与我们联系。

Search Other Lawyers
ANWALTSSUCHE
搜寻其他律师